What's in Mercy Health Ohio's pipeline?

Mercy Health Ohio has 4 drugs in our index: 3 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Mercy Health Ohio's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Astellas Pharma Inc, Benazir Bhutto Hospital, Rawalpindi, Berinstein, Jeffrey, Celgene.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mercy-health-ohio.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Mercy Health Ohio — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mercy Health Ohio pipeline: 3 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Cefazolin + Gentamicin	Cefazolin + Gentamicin	marketed	Beta-lactam antibiotic + aminoglycoside antibiotic combination	Bacterial penicillin-binding proteins (cefazolin); bacterial 30S ribosomal subunit (gentamicin)	Infectious Disease
Methylprednisolone Injection [Solu-Medrol]	Methylprednisolone Injection [Solu-Medrol]	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor	Immunology, Rheumatology, Oncology (supportive care)
Clindamycin + Gentamicin	Clindamycin + Gentamicin	marketed	Antibiotic combination (lincosamide + aminoglycoside)	Bacterial ribosome (50S subunit for clindamycin; 30S subunit for gentamicin)	Infectious Disease
Droperidol Injectable Product	Droperidol Injectable Product	phase 3	Butyrophenone antipsychotic	Dopamine D2 receptor	Psychiatry / Acute Care

Therapeutic area mix

Infectious Disease · 2
Immunology, Rheumatology, Oncology (supportive care) · 1
Psychiatry / Acute Care · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
Benazir Bhutto Hospital, Rawalpindi · 1 shared drug class
Berinstein, Jeffrey · 1 shared drug class
Celgene · 1 shared drug class
Children's Hospital of Philadelphia · 1 shared drug class
Chong Kun Dang Pharmaceutical · 1 shared drug class
Ain Shams University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Mercy Health Ohio:

Cite this brief

Drug Landscape (2026). Mercy Health Ohio — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mercy-health-ohio. Accessed 2026-05-18.